 The UW Carbone Cancer Center (UWCCC) Nuclear Signaling Research Program seeks to understand molecular mechanisms underlying transcriptional, posttranscriptional and DNA damage responses in normal growth and differentiation processes and reveal how these mechanisms impact tumor formation, progression and therapy resistance.
Program Leader (pictured left)
Shigeki Miyamoto, PhD
Co-Leader
Caroline Alexander, PhD
Program Profile for Full Members
Full Membership:
20 members
12 departments
2 schools
Project Funding as of 10/2009 (direct costs):
Peer-reviewed |
$9.4M
|
47 |
NCI |
$1.7M |
11 |
NIH |
$6.4M |
24 |
ACS |
$0.4M |
4 |
NSF |
$0.1M |
2 |
Other |
$0.8M |
6 |
| Non peer-reviewed |
$0.9M |
12 |
| Total |
$10.3M |
59 |
Publications
(Full members only)
| |
2007 |
2008 |
2009
(6 mo) |
| Total |
60 |
64 |
37 |
| Intra-Programmatic* |
|
|
|
| Inter-Progtrammatic* |
|
|
|
*Not mutually exclusive
Program Participants
Full Members
Elaine
T. Alarid, PhD
Caroline Alexander, PhD
Richard A. Anderson
Mark E. Burkard, MD, PhD
Wade Bushman, Ph.D, MD
Sinisa Dovat, MD
Peiman Hematti, MD
David F. Jarrard, MD
James L. Keck, PhD
Shigeki Miyamoto, PhD
|
Jeff Ross, MD
Linda A. Schuler, PhD
Igor Slukvin, MD, PhD
John P. Svaren, PhD
James Thomson, VMD, PhD
Randal
S. Tibbetts, PhD
David A. Wassarman, PhD
Jyoti J. Watters, PhD
David T. Yang, MD
Jing Zhang, PhD |
Affiliate Members

Michael K Fritsch MD, PhD
Joan S. Jorgensen, DVM, PhD |
|